Prostate cancer is a significant public health burden and a major cause of morbidity and
mortality among men worldwide. Analyzing geographic patterns and temporal trends may help …

Background Several passive surveillance systems reported increased risks of myocarditis or
pericarditis, or both, after COVID-19 mRNA vaccination, especially in young men. We used …

Background: Individual studies have suggested that circulating carotenoids, retinol, or
tocopherols may be associated with prostate cancer risk, but the studies have not been large …

The bivalent (original and Omicron BA.4/BA.5) mRNA-1273 COVID-19 vaccine was authorized
to offer broader protection against COVID-19. We conducted a matched cohort study to …

The prevalence of fusions of the transmembrane protease, serine 2, gene (TMPRSS2) with
the erythroblast transformation-specific–related gene (ERG), or TMPRSS2:ERG, in prostate …

Despite the increasing number of studies conducted recently to evaluate the association
between HPV infections and the risk of prostate cancer, the results remain inconclusive. …

Background Monitoring safety outcomes following COVID-19 vaccination is critical for
understanding vaccine safety especially when used in key populations such as elderly persons …

Circulating insulin-like growth factor-1 (IGF-1) is consistently associated with prostate cancer
risk. IGF-1 binds to IGF-1 receptor (IGF1R) and insulin receptor (IR), activating cancer …

Background The US Food and Drug Administration (FDA) Biologics Effectiveness and
Safety (BEST) Initiative conducts active surveillance of adverse events of special interest (AESI) …

Background Although frequently used in the early pandemic, data on the effectiveness of
COVID-19 convalescent plasma (CCP) remain mixed. We investigated the effectiveness and …